Beyond-Mild Psoriasis: A Consensus Statement on Calcipotriol and Betamethasone Dipropionate Foam for the Topical Treatment of Adult Patients

[1] Parisi R(2013)Global epidemiology of psoriasis: a systematic review of incidence and prevalence J Invest Dermatol 133 377-385

[2] Symmons DPM(2018)Defining and treating moderate plaque psoriasis: a dermatologist survey J Dermatolog Treat 29 658-663

[3] Griffiths CEM(2018)Psychosocial distress of patients with psoriasis: protocol for an assessment of care needs and the development of a supportive intervention JMIR Res Protoc. 7 e22-453

[4] Ashcroft DM(2014)A consensus report on appropriate treatment optimization and transitioning in the management of moderate-to-severe plaque psoriasis J Eur Acad Dermatol Venereol 28 438-659

[5] Knuckles MLF(2009)Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies J Am Acad Dermatol 60 643-967

[6] Levi E(2013)Topical therapies for the treatment of plaque psoriasis: systematic review and network meta-analyses Br J Dermatol 168 954-178

[7] Soung J(2021)Topical treatment of psoriasis vulgaris: the Swiss treatment pathway Dermatology 237 166-470

[8] Zill JM(2021)Joint AAD–NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures J Am Acad Dermatol 84 432-636

[9] Dirmaier J(2017)British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017 Br J Dermatol 177 628-13

[10] Augustin M(2018)Choosing first-line biologic treatment for moderate-to-severe psoriasis: what does the evidence say? Am J Clin Dermatol 19 1-674

[1] Parisi R(2013)Global epidemiology of psoriasis: a systematic review of incidence and prevalence J Invest Dermatol 133 377-385

[2] Symmons DPM(2018)Defining and treating moderate plaque psoriasis: a dermatologist survey J Dermatolog Treat 29 658-663

[3] Griffiths CEM(2018)Psychosocial distress of patients with psoriasis: protocol for an assessment of care needs and the development of a supportive intervention JMIR Res Protoc. 7 e22-453

[4] Ashcroft DM(2014)A consensus report on appropriate treatment optimization and transitioning in the management of moderate-to-severe plaque psoriasis J Eur Acad Dermatol Venereol 28 438-659

[5] Knuckles MLF(2009)Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies J Am Acad Dermatol 60 643-967

[6] Levi E(2013)Topical therapies for the treatment of plaque psoriasis: systematic review and network meta-analyses Br J Dermatol 168 954-178

[7] Soung J(2021)Topical treatment of psoriasis vulgaris: the Swiss treatment pathway Dermatology 237 166-470

[8] Zill JM(2021)Joint AAD–NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures J Am Acad Dermatol 84 432-636

[9] Dirmaier J(2017)British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017 Br J Dermatol 177 628-13

[10] Augustin M(2018)Choosing first-line biologic treatment for moderate-to-severe psoriasis: what does the evidence say? Am J Clin Dermatol 19 1-674